Ignite Creation Date:
2024-05-05 @ 5:26 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00450307
Status:
COMPLETED
Last Update Posted:
2013-10-16
First Post:
2007-03-20
Brief Title:
Monoclonal Antibody 3F8 and GM-CSF in Treating Young Patients With High-Risk Refractory or Relapsed Neuroblastoma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-06
Start Date Type:
None
Primary Completion Date:
2013-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-04
Completion Date Type:
ACTUAL
First Submit Date:
2007-03-20
First Submit QC Date:
March 20 2007
Study First Post Date:
2007-03-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-10-14
Last Update Post Date:
2013-10-16
Last Update Post Date Type:
ESTIMATED